RELMADA THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Liabilities
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Other Noncurrent Liabilities of -$1.49 thousand for the 9-month period ending 2017-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2018-05-14
- RELMADA THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-09-30 was -$6.18K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2016-06-30 was $31.93K.
- RELMADA THERAPEUTICS, INC. increase (decrease) in other noncurrent liabilities for fiscal 2016 was $140.91K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$1.49K 10-Q · filed 2018-05-14 | |||
| 2016-09-30 | -$6.18K 10-Q · filed 2017-11-14 | $25.75K derived: sum of 2 quarters · filed 2017-11-14 | ||
| 2016-06-30 | $31.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $140.91K 10-K · filed 2017-09-28 | ||
| 2016-03-31 | $108.98K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |